Skip to content
healthcare.dev

Loratadine Allergy Relief

NDC 10135-763, Loratadine, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-763
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076134
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-763 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
10135-763-0310135076303300 TABLET in 1 BOTTLE (10135-763-03)
10135-763-301013507633030 TABLET in 1 BOTTLE (10135-763-30)
10135-763-901013507639090 TABLET in 1 BOTTLE (10135-763-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10135-763 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-763 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-763. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.